Invention Grant
- Patent Title: Aprepitant oral liquid formulations
-
Application No.: US15333529Application Date: 2016-10-25
-
Publication No.: US10251891B2Publication Date: 2019-04-09
- Inventor: Udaya Toti , Shyamprasad Mukundan , Sasank Chaitanya Kunadharaju , Tushar Hingorani , Kumaresh Soppimath , Satish Pejaver , Navneet Puri
- Applicant: InnoPharma, Inc.
- Applicant Address: US NJ Piscataway
- Assignee: InnoPharma, Inc.
- Current Assignee: InnoPharma, Inc.
- Current Assignee Address: US NJ Piscataway
- Agent Jason G. Tebbutt
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K9/00 ; A61K47/12 ; A61K9/10 ; A61K47/38 ; A61K47/20 ; A61K9/14
Abstract:
A liquid pharmaceutical compositions comprising Aprepitant is preferably prepared as an oral suspension dosage form for the prevention and control of acute and delayed chemotherapy induced nausea and vomiting, and/or for prevention of postoperative nausea and vomiting.
Public/Granted literature
- US20170035774A1 APREPITANT ORAL LIQUID FORMULATIONS Public/Granted day:2017-02-09
Information query
IPC分类:
